期刊文献+

RP-HPLC法测定5-Fu磁性微球及小鼠各组织中5-Fu的含量 被引量:3

Determination of 5-Fluorouracil in Magnetic Micropheres and Tissues in Mice by RP-HPLC
原文传递
导出
摘要 目的:以反相高效液相色谱法测定5-氟尿嘧啶(5-Fu)磁性微球及小鼠各组织中5-Fu的含量,并评价5-Fu磁性微球在小鼠体内的靶向性。方法:15只小鼠尾静脉注射5-Fu及其磁性微球,采用0.5%胃蛋白酶消解磁性微球后经乙酸乙酯2次萃取后以反相高效液相色谱法测定心、肝、肾、脾、肺、脑和肌肉等组织匀浆中5-Fu含量。结果:组织匀浆中5-Fu检测浓度在0.1~25mg·L-1范围内线性关系良好,最低检测浓度为0.1mg·L-1。与注射单一5-Fu对照品比较,小鼠静脉注射5-Fu磁性微球后在肝脏分布明显增加(P<0.05),加入磁性支架和体表磁场的肌肉组织中可见5-Fu分布。结论:本方法适用于测定磁性微球及小鼠各组织中5-Fu的含量;5-Fu磁性微球具有肝靶向性和磁靶向性。 OBJECTIVE: To establish a RP - HPLC method for the determination of 5- fluorouracil(5- Fu) in magnetic micropheres (MMS), and to evaluate the target ability of 5- Fu magnetic microspheres in mice. METHODS: 5- Fu- MMS was digested with 0.5% pepsin, and then free 5 Fu was extracted from tissue with ethyl acetate, and detected by a validated RP -HPLC method. RESULTS: The calibration curve was linear over the range of 0.1--25mg·L^-1 and the limit of quan- t ization was 0. 1mg ·L^-1. The tissue distribution of 5 Fu-MMS in the liver was significantly increased as compared to control(P〈0.05); Furthermore, 5- Fu- MMS was detected in muscle by using an internal magnetic holder and externally applied magnetic field in muscle section. CONCLUSION .The established HPLC method is suitable for the study of 5- Fu content in magnetic - microspheres and tissues, and for the evaluation of the target ability of 5- Fu MMS in mice; 5- Fu - MMS has remarkable hepatic targeting and good magnetic targeting.
出处 《中国药房》 CAS CSCD 北大核心 2007年第7期497-499,共3页 China Pharmacy
基金 国家科技部863课题(2002AA214061)
关键词 5-氟尿嘧啶 磁性微球 反相高效液相色谱法 靶向治疗 组织分布 5- Fluorouracil Magnetic micropheres RP - HPLC Target therapy Tissue distribution
  • 相关文献

参考文献6

二级参考文献23

  • 1郑根建,周嘉秀,李德伦,周岚.平阳霉素磁控缓释微球的制备[J].华西口腔医学杂志,1996,14(3):220-222. 被引量:7
  • 2胡良平,现代统计学与SAS应用,1996年,66页 被引量:1
  • 3中华人民共和国药典.二部,1995年,431页 被引量:1
  • 4Kovac AL.Benefits and risks of newer treatment for chemotherapy- induced and postoperative nausea and vomiting[J ]. Drug Saf, 2003,26(4) : 227. 被引量:1
  • 5Griffiths JR, Glickson JD. Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy [J]. Adv Drug Delivery Rev, 2000,41 (1): 75-89. 被引量:1
  • 6Nagano H, Machida Y, Iwata M, et al. Preparation of magnetic granules containing bleomycin and its evaluation using model esophageal cancer[J]. Int J Pharm, 1997, 147 (1):119-125. 被引量:1
  • 7Kueckelhaus S, Reis SC, Carneiro MF, et al. In vivo investigation of cobalt ferrite-based magnetic fluid and magnetoliposomes using morphological tests [J]. J Magn Magn Mater, 2004, 272-276: 2402-2403. 被引量:1
  • 8Halbreich A, Groman EV, Raison D, et al. Damage to the protein synthesizing apparatus in mouse liver in vivo by magnetocytolysis in the presence of hepatospecific magnetic nanoparticles [J]. J Magn Magn Mater, 2003, 248 (2): 276-285. 被引量:1
  • 9Weissleder R, Stark DD, Engelstad BL, et al. Superparamaggnetic iron oxides: pharmacokinetics and toxicity [J]. Am Jroent, 1989, 152-167. 被引量:1
  • 10Lacava LM, Garcia VAP, Kuckelhaus S, et al. Long-term retention of dextran-coated magnetite nanoparticles in the liver and spleen[J]. J Magn Magn Mater, 2004, 272-276:2434-2435. 被引量:1

共引文献32

同被引文献16

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部